Showing results (2101-2110 of 9,904) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|July 22, 2014
Immunogenicity of a live-attenuated Japanese encephalitis vaccine in children and adolescents after hematopoietic stem cell transplantationS Pakakasama, S Wattanatitan, C Techasaensiri, et al.
Bone Marrow Transplantation|July 29, 2014
Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemiaG Lucarelli, A Isgrò, P Sodani, et al.
Bone Marrow Transplantation|July 29, 2014
Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility studyC R Kelsey, J M Scott, A Lane, et al.
Bone Marrow Transplantation|August 5, 2014
Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCTX-Y Qin, G-X Li, Y-Z Qin, et al.
Bone Marrow Transplantation|November 5, 2013
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapyS K Kumar, J Mikhael, B Laplant, et al.
Bone Marrow Transplantation|November 5, 2013
Similar outcomes between adolescent/young adults and children with AML following allogeneic hematopoietic cell transplantationM J Burke, N Gossai, Q Cao, et al.
Bone Marrow Transplantation|March 22, 2016
Post-relapse survival after haploidentical transplantation vs matched-related or matched-unrelated hematopoietic cell transplantationM Solh, X Zhang, K Connor, et al.
Bone Marrow Transplantation|April 5, 2016
Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipientsC Espina, I Jenkins, L Taylor, et al.
Bone Marrow Transplantation|April 5, 2016
Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivorsP Anandi, N A Jain, X Tian, et al.
Bone Marrow Transplantation|April 12, 2016
Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHDF He, E Warlick, J S Miller, et al.
Pageof 991